Symbol="GMDA"
AssetType="Common Stock"
Name="Gamida Cell Ltd"
Description="Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company is headquartered in Jerusalem, Israel."
CIK="1600847"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="5 NAHUM HAFZADI STREET, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="147822000"
EBITDA="-74816000"
PERatio="None"
PEGRatio="None"
BookValue="-0.187"
DividendPerShare="0"
DividendYield="0"
EPS="-1.17"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.41"
ReturnOnEquityTTM="-16.66"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.35"
EVToRevenue="-"
EVToEBITDA="-1.506"
Beta="1.548"
num_52WeekHigh="3.66"
num_52WeekLow="0.56"
num_50DayMovingAverage="1.842"
num_200DayMovingAverage="1.577"
SharesOutstanding="105587000"
DividendDate="None"
ExDividendDate="None"
symbol="GMDA"
open="1.34"
high="1.42"
low="1.34"
price="1.40"
volume="907138.00"
latest_trading_day="2023-07-28"
previous_close="1.32"
change="0.08"
change_percent="6.0606%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="20"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="80"
Volume_recent_avg="3971791"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.96"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="80"
Aroon_momentum_negative="20"
image_negative_thumbnail_id_1="93"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0083.jpeg"
image_negative_thumbnail_id_2="96"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_neutral_thumbnail_id_1="559"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="700"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_positive_thumbnail_id_2="954"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0116.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1179"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
